Soy product consumption and the risk of all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis of cohort studies.

Currently, the association of soy intake with total- and cause-specific mortality is inconsistent. The aim of this study was to systematically review cohort studies on the association between the consumption of soy products and mortality from all-causes, cardiovascular disease (CVD), and cancer. We conducted a systematic search of the PubMed/Medline, ISI Web of Knowledge and Embase electronic databases up to October 2016. Prospective cohort studies that examined the association of soy products with the risk of all-cause, CVD and cancer mortality using the relative risk (RR) or Hazard Ratio (HR) with 95% CIs were considered. Random-effect models were used to pool the study results and heterogeneity was examined using the I2 index and Q test. Finally, 7 studies were included for the meta-analysis; three studies reported the risk of all-cause mortality. Four studies assessed the risk of mortality from CVD and cancer. In total, 39 250 deaths were reported among 627 209 participants in a 7 to 18-year follow-up. A high consumption of soy products was not significantly associated with a lower risk of mortality from all-causes (HR: 0.96, 95% CI: 0.90, 1.02, I2: 38.5%, and Pheterogeneity = 0.14), CVD (HR: 0.95, 95% CI: 0.82, 1.10, I2: 49.9%, and Pheterogeneity = 0.07), and cancer (HR: 0.98, 95% CI: 0.92, 1.05, I2: 0%, and Pheterogeneity = 0.75). These findings indicated no significant association between a high intake of soy products and all-cause, CVD, and cancer mortality. Further studies are needed to clarify the association between the types of soy products and the risk of mortality.

[1]  U. Nöthlings,et al.  Association of isoflavone biomarkers with risk of chronic disease and mortality: a systematic review and meta-analysis of observational studies , 2017, Nutrition reviews.

[2]  E. Giovannucci,et al.  Dietary Flavonoid and Lignan Intake and Mortality in Prospective Cohort Studies: Systematic Review and Dose-Response Meta-Analysis , 2017, American journal of epidemiology.

[3]  B. Larijani,et al.  Alpha-lipoic acid supplement in obesity treatment: A systematic review and meta-analysis of clinical trials. , 2017, Clinical nutrition.

[4]  T. Tamura,et al.  Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. , 2017, The American journal of clinical nutrition.

[5]  Z. Yan,et al.  Association between consumption of soy and risk of cardiovascular disease: A meta-analysis of observational studies , 2017, European journal of preventive cardiology.

[6]  Y. Je,et al.  Flavonoid Intake and Mortality from Cardiovascular Disease and All Causes: A meta‐analysis of prospective cohort studies , 2016, Clinical nutrition ESPEN.

[7]  J. Gaziano,et al.  Soya products and serum lipids: a meta-analysis of randomised controlled trials , 2015, British Journal of Nutrition.

[8]  K. Kayaba,et al.  Soy and Soy Products Intake, All-Cause Mortality, and Cause-Specific Mortality in Japan , 2015, Asia-Pacific journal of public health.

[9]  Josette F. Jones,et al.  Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey , 2015, European Journal of Nutrition.

[10]  A. Franke,et al.  Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk. , 2015, Molecular nutrition & food research.

[11]  Jian-Min Yuan,et al.  Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. , 2014, The Journal of nutrition.

[12]  S. Ho,et al.  Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. , 2014, Molecular nutrition & food research.

[13]  E. Riboli,et al.  Behavioral and dietary risk factors for noncommunicable diseases. , 2013, The New England journal of medicine.

[14]  Jin-Qiang Chen,et al.  Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms , 2013 .

[15]  C. Slupsky,et al.  Daidzein Metabolizing Phenotypes and Nutritional Metabolomics Profiling After a Soy Intervention: A Pilot Study , 2013 .

[16]  V. Emmanuele,et al.  Tissue‐specific oxidative stress and loss of mitochondria in CoQ‐deficient Pdss2 mutant mice , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Fraser,et al.  Vegetarian Diets and the Incidence of Cancer in a Low-risk Population , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[18]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[19]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[20]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[21]  E. Spitznagel,et al.  Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. , 2009, The American journal of clinical nutrition.

[22]  Y. Kokubo,et al.  Association of Dietary Intake of Soy, Beans, and Isoflavones With Risk of Cerebral and Myocardial Infarctions in Japanese Populations: The Japan Public Health Center–Based (JPHC) Study Cohort I , 2007, Circulation.

[23]  A. Tamakoshi,et al.  Dietary Habits and Risk of Ovarian Cancer Death in a Large-Scale Cohort Study (JACC Study) in Japan , 2007, Nutrition and cancer.

[24]  D. Jacobs,et al.  Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. , 2007, The American journal of clinical nutrition.

[25]  F. Sacks,et al.  Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee , 2006, Circulation.

[26]  A. Tamakoshi,et al.  Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. , 2004, The Kurume medical journal.

[27]  S. Gomez,et al.  Soy and isoflavone consumption in relation to prostate cancer risk in China. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  Andrea Bonanome,et al.  Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. , 2002, The American journal of medicine.

[29]  C. Nagata,et al.  Soy and fish oil intake and mortality in a Japanese community. , 2002, American journal of epidemiology.

[30]  C. Nagata,et al.  A prospective cohort study of soy product intake and stomach cancer death , 2002, British Journal of Cancer.

[31]  T. Mizoue,et al.  Dietary factors and stomach cancer mortality , 2002, British Journal of Cancer.

[32]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[33]  M. Ando,et al.  Dietary Habits and Risk of Lung Cancer Death in a Large‐scale Cohort Study (JACC Study) in Japan by Sex and Smoking Habit , 2001, Japanese journal of cancer research : Gann.

[34]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[35]  C. D’Adamo,et al.  Soy foods and supplementation: a review of commonly perceived health benefits and risks. , 2014, Alternative therapies in health and medicine.

[36]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[37]  K. Reynolds,et al.  Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial , 2013, European Journal of Clinical Nutrition.

[38]  H. Iso,et al.  Nutrition and disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). , 2007, Asian Pacific journal of cancer prevention : APJCP.

[39]  K. Tsai,et al.  Construction of a 3D model of nattokinase, a novel fibrinolytic enzyme from Bacillus natto. A novel nucleophilic catalytic mechanism for nattokinase. , 2005, Journal of molecular graphics & modelling.

[40]  M. Mori,et al.  Dietary habits and cancer mortality among middle aged and older Japanese living in hokkaido, Japan by cancer site and sex. , 2004, Asian Pacific journal of cancer prevention : APJCP.

[41]  T. Hirayama.  Contribution of a long-term prospective cohort study to the issue of nutrition and cancer with special reference to the role of alcohol drinking. , 1990, Progress in clinical and biological research.